Related Experiment Videos
[Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future]
S I Gamidov1, R I Ovchinnikov1, A Yu Popova1
1Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
Urologiia (Moscow, Russia : 1999)
|April 11, 2017
Abstract:
This review article describes the differences in efficacy and side effects between available phosphodiesterase type 5 (PDE-5) inhibitors used for treating erectile dysfunction. The most studied PDE-5 inhibitor is sildenafil.